Potential use of buccal epithelium for genetic diagnosis of atherosclerosis using mtDNA mutations

Vasily V. Sinyov , Margarita A. Sazonova , Anastasia I. Ryzhkova , Elena V. Galitsyna , Alexsandra A. Melnichenko , Anton Y. Postnov , Alexander N. Orekhov , Andrey V. Grechko , Igor A. Sobenin

Vessel Plus ›› 2017, Vol. 1 ›› Issue (1) : 145 -50.

PDF
Vessel Plus ›› 2017, Vol. 1 ›› Issue (1) :145 -50. DOI: 10.20517/2574-1209.2016.04
Short Communication
Short Communication

Potential use of buccal epithelium for genetic diagnosis of atherosclerosis using mtDNA mutations

Author information +
History +
PDF

Abstract

Aim: The aim of this pilot study was to compare the heteroplasmy levels of specific mitochondrial (mt)DNA mutations in human buccal epithelial and whole blood cells in participants with different degrees of predisposition to atherosclerosis. The potential for buccal epithelium to be used for the genetic diagnosis of atherosclerosis using mtDNA mutations was assessed.

Methods: Samples of buccal epithelial and whole blood cells were obtained from 134 donors. DNA was extracted from the samples and subjected to polymerase chain reaction and pyrosequencing. The threshold heteroplasmy levels of the mutations m.12315G>A, m.3336T>C, m.1555А>G, m.13513G>A, and m.3256C>T were analyzed in order to assess the potential for using buccal epithelium and whole blood for the genetic diagnosis of atherosclerosis.

Results: The threshold heteroplasmy levels of the assessed mitochondrial mutations did not significantly differ between buccal epithelial and whole blood cells.

Conclusion: Buccal epithelial cells may be preferable to whole blood cells for analyzing the association of mitochondrial genome mutations with atherosclerosis.

Keywords

Buccal cell / mutation / mtDNA / threshold heteroplasmy level / mitochondrial genome / atherosclerosis

Cite this article

Download citation ▾
Vasily V. Sinyov, Margarita A. Sazonova, Anastasia I. Ryzhkova, Elena V. Galitsyna, Alexsandra A. Melnichenko, Anton Y. Postnov, Alexander N. Orekhov, Andrey V. Grechko, Igor A. Sobenin. Potential use of buccal epithelium for genetic diagnosis of atherosclerosis using mtDNA mutations. Vessel Plus, 2017, 1(1): 145-50 DOI:10.20517/2574-1209.2016.04

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Sazonova MA,Khasanova ZB,Sobenin IA.Direct quantitative assessment of mutant allele in mitochondrial genome in atherosclerotic lesion of human aorta..Atheroscler Suppl2007;8:45-6

[2]

Postnov AY,Budnikov YY,Sobenin IA.PO5-116 Association of somatic mitochondrial mutations with atherosclerosis..Atheroscler Suppl2007;8:46

[3]

Sobenin IA,Ivanova MM,Myasoedova VA,Nurbaev SD,Orekhov AN.Mutation C3256T of mitochondrial genome in white blood cells: novel genetic marker of atherosclerosis and coronary heart disease..PLoS One2012;7:e46573 PMCID:PMC3462756

[4]

Sobenin IA,Postnov AY,Orekhov AN.Mitochondrial mutations are associated with atherosclerotic lesions in the human aorta..Clin Dev Immunol2012;2012:832464

[5]

Li H,Lu J.Physiology and pathophysiology of mitochondrial DNA..Adv Exp Med Biol2012;942:39-51 PMCID:PMC4706180

[6]

de Laat P,van den Heuvel LP,Janssen MC.Clinical features and heteroplasmy in blood, urine and saliva in 34 Dutch families carrying the m.3243A>G mutation..J Inherit Metab Dis2012;35:1059-69 PMCID:PMC3470685

[7]

Naue J,Sänger T,Hatzer-Grubwieser P,Lutz-Bonengel S.Evidence for frequent and tissue-specific sequence heteroplasmy in human mitochondrial DNA..Mitochondrion2015;20:82-94

[8]

Chinnery PF,Walker M,Taylor RW,Bindoff L.Nonrandom tissue distribution of mutant mtDNA..Am J Med Genet1999;85:498-501

[9]

Miasoedova VA,Orekhova VA,Mukhamedova NM,Karagodin VP.Study of intima-medial thickness (IMT) of the carotid arteries as an indicator of natural atherosclerosis progress in Moscow population..Patol Fiziol Eksp Ter2012;(3):104-8

[10]

Sazonova MA,Sobenin IA.Mitochondrial genome defects andatherosclerosis.Role of mitochondrial genome pathologies in atherosclerotic lesionsformation of an arterial wall. Palmarium Academic Publishing2014;(in Russian)

[11]

Sazonova M,Khasanova Z,Postnov A.Studies of the human aortic intima by a direct quantitative assay of mutant alleles in the mitochondrial genome..Atherosclerosis2009;204:184-90

[12]

Sazonova MA,Barinova VA,Zhelankin AV,Sobenin IA,Orekhov AN.Mosaicism of mitochondrial genetic variation in atherosclerotic lesions of the human aorta..Biomed Res Int2015;2015:825468

[13]

Alderborn A,Hammerling U.Determination of single-nucleotide polymorphisms by real-time pyrophosphate DNA sequencing..Genome Res2000;10:1249-58 PMCID:PMC310924

[14]

IBM Analytics. IBM SPSS. Available from: http://www.ibm.com/analytics/us/en/technology/spss/spss-trials.html#spss-trials%20n.d. [Last accessed on Jan 17, 2017]

[15]

Wallace DC,Lott MT.Mitochondrial DNA variation in human evolution and disease..Gene1999;238:211-30

[16]

Frederiksen AL,Kyvik KO,Vissing J.Tissue specific distribution of the 3243A->G mtDNA mutation..J Med Genet2006;43:671-7 PMCID:PMC2564591

[17]

Litvinova NA,Nikolaeva EA.Tissue-specific features of mitochondrial DNA polymorphisms..Russian Bull Perinatol Pediatr2015;60:76-8

[18]

Pyle A,Durham SE,Schaefer AM,Chinnery PF.Depletion of mitochondrial DNA in leucocytes harbouring the 3243A->G mtDNA mutation..J Med Genet2007;44:69-74 PMCID:PMC2597915

[19]

Spyropoulos A,Horvath R,Yu-Wai-Man P,Taylor RW.Near-identical segregation of mtDNA heteroplasmy in blood, muscle, urinary epithelium, and hair follicles in twins with optic atrophy, ptosis, and intractable epilepsy..JAMA Neurol2013;70:1552-5

[20]

Lee HY,Park MJ,Han GR.Differential distribution of human mitochondrial DNA in somatic tissues and hairs..Ann Hum Genet2006;70:59-65

[21]

Roberts KA.Characterization of mitochondrial DNA sequence heteroplasmy in blood tissue and hair as a function of hair morphology..J Forensic Sci2011;56:46-60

AI Summary AI Mindmap
PDF

29

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/